Discontinuation of MBL products
First of all, please accept our sincere gratitude for your continued support.
Unfortunately, we are discontinuing the production of the following products.
Allow us to apologize for any inconvenience this may have caused you.
Thank you very much for your understanding and cooperation.
Discontinuation date：March 31, 2019
|D251-3||Anti-SPA-1 mAb||100 µg/100 µL||-|
|D252-3||Anti-CD9 (Human) mAb||100 µg/100 µL||-|
|D257-3||Anti-CD55 (DAF) (Human) mAb||100 µg/100 µL||-|
|D260-3||Anti-CD98 heavy chain (Human) mAb||100 µg/100 µL||-|